Squarer Ron Insider Trades

Insider Trading History

Track insider trading activity for Squarer Ron. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $1.78M 39,375 shares
Last Trade
May 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$676k 16,000 shares
$42.26
$45.20
Nuvalent
Nuvalent NUVL
Director
Holding Value $398k 4,418 shares
Last Trade
Dec 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$767k 7,255 shares
$105.69
$90.18
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Director
Holding Value $288k 93,627 shares
Last Trade
Jun 13, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$54.4k 15,184 shares
$3.58
$3.08
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Director
Holding Value $335k 108,811 shares
Last Trade
Jun 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$144k 40,000 shares
$3.59
$3.08
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $1.6M 35,375 shares
Last Trade
May 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$412k 19,500 shares
$21.15
$45.20
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Director
Holding Value $248k 80,663 shares
Last Trade
Jun 17, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$20.2k 6,995 shares
$2.89
$3.08
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Director
Holding Value $270k 87,658 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$126k 40,000 shares
$3.16
$3.08
Nano Labs
Nano Labs NA
Director
Holding Value $0 0 shares
Last Trade
Jun 11, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$304k 66,066 shares
$4.60
$2.30
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $1.31M 28,875 shares
Last Trade
May 08, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$133k 19,500 shares
$6.82
$45.20
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals DCPH
Director
Holding Value $121k 4,727 shares
Last Trade
Jan 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$68.4k 4,727 shares
$14.46
$25.59
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Director
Holding Value $110k 35,806 shares
Last Trade
Jan 02, 2024 Sale
$366k 216,274 shares
$1.69
$3.08
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Director
Holding Value $147k 47,658 shares
Last Trade
Jan 02, 2024 Sale
$1.62M 958,179 shares
$1.69
$3.08
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Director
Holding Value $0 0 shares
Last Trade
Jan 02, 2024 Sale
$793k 468,977 shares
$1.69
$3.08
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals DCPH
Director
Holding Value $768k 30,000 shares
Last Trade
Jun 21, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$447k 30,000 shares
$14.91
$25.59
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $1.01M 22,375 shares
Last Trade
May 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$231k 13,500 shares
$17.11
$45.20
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals DCPH
Director
Holding Value $83.7k 3,269 shares
Last Trade
Jan 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$69.5k 3,269 shares
$21.27
$25.59
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals DCPH
Director
Holding Value $473k 18,500 shares
Last Trade
Jun 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$259k 18,500 shares
$13.98
$25.59
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $808k 17,875 shares
Last Trade
May 11, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$449k 21,000 shares
$21.38
$45.20
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals DCPH
Director
Holding Value $245k 9,570 shares
Last Trade
Jan 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$79.1k 9,570 shares
$8.27
$25.59
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals DCPH
Director
Holding Value $307k 12,000 shares
Last Trade
Jun 23, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$430k 12,000 shares
$35.86
$25.59

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up